Orange Book product · Generic (ANDA)
HYDROXYZINE PAMOATE
HYDROXYZINE PAMOATE
At a glance
Jun 03, 2013
Approved
Generic (ANDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Jun 03, 2013
13 yr 3 mo ago
Today
Pharmaceutical detail
Active ingredient
HYDROXYZINE PAMOATE
Strength
EQ 25MG HYDROCHLORIDE
Dosage form
CAPSULE
Route
ORAL
TE code
AB
Application
ANDA 201507
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of HYDROXYZINE PAMOATE
- —VISTARILBrand (NDA)
NDA 011459 · PFIZER
- —VISTARILBrand (NDA)
NDA 011795 · PFIZER
- 1996HYDROXYZINE PAMOATEGeneric (ANDA)
ANDA 040156 · IMPAX LABS INC
- 1991HYDROXYZINE PAMOATEGeneric (ANDA)
ANDA 081165 · WATSON LABS
- 1991HYDROXYZINE PAMOATEGeneric (ANDA)
ANDA 081127 · BEXIMCO PHARMS USA
- 1991HYDROXYZINE PAMOATEGeneric (ANDA)
ANDA 081128 · SANDOZ
- 1991HYDROXYZINE PAMOATEGeneric (ANDA)
ANDA 081129 · SANDOZ
- 1987HYDROXYZINE PAMOATEGeneric (ANDA)
ANDA 089031 · SUPERPHARM
- 1987HYDROXYZINE PAMOATEGeneric (ANDA)
ANDA 089032 · SUPERPHARM
- 1987HYDROXYZINE PAMOATEGeneric (ANDA)
ANDA 089033 · SUPERPHARM
- 1986HYDROXYZINE PAMOATEGeneric (ANDA)
ANDA 089145 · PAR PHARM
- 1986HYDROXYZINE PAMOATEGeneric (ANDA)
ANDA 089146 · PAR PHARM
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
